Ｐａｇｅ 145525 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 通常モードに戻る ┃ ＩＮＤＥＸ ┃ ≪前へ │ 次へ≫ ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ▼Jerini Receives uE rapFressirl 08/7/16(水) 23:54 ─────────────────────────────────────── ■題名 ： Jerini Receives uE ■名前 ： rapFressirl <asdfhger@googlemail.com> ■日付 ： 08/7/16(水) 23:54 ■Ｗｅｂ ： http://doxpx.com -------------------------------------------------------------------------
| BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 15, 2008 /PRNewswire-FirstCall/ -- Shire minimal , the wide-ranging specialty biopharmaceutical retinue, notes that Jerini AG has announced today that the European Commission has granted the New Zealand marketing authorization for its possibility combination FIRAZYR(R) (Icatibant) in the treatment of grave attacks of inherited angioedema (HAE). HAE is a debilitating and potentially sprightliness-intimidating genetic bug characterized by impetuousz and recurring attacks of edema. As announced by Shire on 3 July, 2008, Maia Elfte Vermogensverwaltungs-GmbH, to be renamed "Shire Deutschlnad Investments GmbH", a German wandering subsidiary of Shire minimal, has launched a unasked societal takeover suggest for all apportionments in Jerini AG. Jerini's managerial and supervision Boards unanimously promote the annals and are recommending acceptance of the comprar viagra to its apportionmentholders. submissive to to finalization of undoubted comprar viagra and win agreements and regis tration of the newly issued allotments, Shire last wishes as experience rights to nearly 75% of Jerini's allotment cap previously the reception of any takeover step acceptances. It is anticipated that the bid choice be communicate for acceptance by the leftover allotmentholders until the end of Q3 2008 and is contingent upon the consummation of undoubted routine terms and conditions, including confirm by allied blending command authorities. |